The bioinformatics among ST-elevated MI, stable CAD patients, and healthy subjects were analyzed and the screened seed genes had been verified as diagnostic and prognostic biomarkers for plaque status changing in CAD progression and MI recurrence, including KLRD1, FOSL2, and LILRB3 (44). This evidence concerns the gene KLRD1 and coronary artery disorder.